FEDERAL COURT OF AUSTRALIA
Nichia Corporation v Arrow Electronics Australia Pty Ltd [2019] FCAFC 2
Appeal from: Nichia Corporation v Arrow Electronics Australia Pty Ltd (No 4) [2017] FCA 864 File number: NSD 1638 of 2017 Judges: BESANKO, JAGOT AND NICHOLAS JJ Date of judgment: 29 January 2019 Catchwords: PATENTS – construction – patent claimed light emitting device which “contains fluorescent material represented by a general formula” – whether “contains” used inclusively or exhaustively – primary judge’s construction preferable – appeal dismissed.
PATENTS – obviousness – inventive step – primary judge’s findings of fact demonstrated no inventive step – claimed invention was obvious – cross-appeal allowed.
Legislation: Patents Act 1990 (Cth) ss 7(2), 18(b)(ii), 40(3) Cases cited: Aktiebolaget Hässle v Alphapharm Pty Ltd [2002] HCA 59; (2002) 212 CLR 411
Aldi Foods Pty Ltd v Moroccanoil Israel Ltd [2018] FCAFC 93; 133 IPR 375
Artcraft Urban Group Pty Ltd v Streetworx Pty Ltd [2016] FCAFC 29; (2016) 245 FCR 485
Astrazeneca AB v Apotex Pty Ltd [2015] HCA 30; (2015) 257 CLR 356
Bitech Engineering v Garth Living Pty Ltd [2010] FCAFC 75; (2010) 86 IPR 468
Brugger v Medic-Aid Ltd [1996] RPC 635
Conor Medsystems Inc v Angiotech Pharmaceuticals Inc [2008] RPC 28
Convatec Ltd v Smith & Nephew Healthcare Ltd (2012) 129 RPC 182
Electric & Musical Industries Ltd v Lissen Ltd [1938] 4 All ER 221
Eli Lilly and Co Ltd v Apotex Pty Ltd [2013] FCA 214; (2013) 100 IPR 451
Fresenius Medical Care Australia Pty Ltd v Gambro Pty Ltd [2005] FCAFC 220; (2005) 224 ALR 168
Generic Health Pty Ltd v Bayer Pharma Aktiengesellschaft [2014] FCAFC 73; (2014) 222 FCR 336
Idenix Pharmaceuticals LLC v Gilead Sciences Pty Ltd [2017] FCAFC 196; (2017) 134 IPR 1
Johns-Manville Corporation’s Patent [1967] RPC 479
Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2004] UKHL 46; [2005] 1 All ER 667
Lockwood Security Products Pty Ltd v Doric Products Pty Ltd [2004] HCA 58; (2004) 217 CLR 274
Multigate Medical Devices Pty Ltd v B Braun Melsungen AG [2016] FCAFC 21; (2016) 117 IPR 1
NV Philips Gloeilampenfabrieken v Mirabella International Pty Limited (1993) 44 FCR 239
Olin Mathieson Chemical Corporation v Biorex Laboratories Ltd [1970] RPC 157
Product Management Group Pty Ltd v Blue Gentian LLC [2015] FCAFC 179; (2015) 240 FCR 85
Welch Perrin & Co Pty Ltd v Worrel [1961] HCA 91; (1961) 106 CLR 588
Wellcome Foundation Limited v VR Laboratories (Aust) Proprietary Limited [1981] HCA 12; (1981) 148 CLR 262
Date of hearing: 21-22 February 2018 Registry: New South Wales Division: General Division National Practice Area: Intellectual Property Sub-area: Patents and Associated Statutes Category: Catchwords Number of paragraphs: 126 Counsel for the appellant: Mr DK Catterns QC with Ms CL Cochrane and Mr DB Larish Solicitor for the appellant: Allens Counsel for the respondent: Ms KJ Howard SC with Mr…
Keep reading for free
Create a free CaseChat account to read Nichia Corporation v Arrow Electronics Australia Pty Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2019] FCAFC 2
- Decision Date
CaseChat Overview and Summary
The court first examined the primary judge's construction of the term "contains" in the patent claims and concluded that it was preferable to interpret it as inclusive rather than exclusive. The evidence provided by Dr Bretschneider was deemed irremediably tainted by hindsight, and thus it was disregarded. The court also noted that the expert evidence summarised by Professor Meijerink, while informative about predictability, did not align with the appropriate application of the Cripps question in this context. The court found that Nichia’s argument regarding the interpretation of "contains" was not substantiated, leading to the dismissal of their appeal.
Regarding the inventive step, the court upheld the primary judge’s findings that the claimed invention was obvious. The evidence presented did not support any inventive step, leading to the conclusion that the invention lacked novelty and was thus obvious. Consequently, the court allowed Arrow’s appeal, affirming that the patent claims were invalid. This decision led to the setting aside of certain orders made by the primary judge, with claims 1 and 3 of the patent declared invalid. The court also ordered that the costs of the appeal and cross-appeal be paid by the appellant to the respondent, with specific orders regarding the costs of the cross-claim.
Orders
Orders of the court
1. The appeal be dismissed.
2. The cross-appeal be allowed.
3. The appellant/cross-respondent pay the respondent/cross-appellant’s costs of the appeal and cross-appeal as agreed or taxed.
4. Orders 2 and 5 and the certificate in paragraph 6 of the orders given on 30 August 2017 be set aside, and in their place the Court:
(a) declares that claims 1 and 3 of Patent No. 720234 were at all material times invalid; and
(b) orders that the cross-respondent pay the cross-claimant’s costs of the cross-claim as agreed or taxed.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.